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OBJECTIVE—Combination antiretroviral therapy (cART) is
associated with lipodystrophy, i.e., loss of subcutaneous adipose
tissue in the abdomen, limbs, and face and its accumulation intra-
abdominally. No fat is lost dorsocervically and it can even
accumulate in this region (buffalo hump). It is unknown how
preserved dorsocervical fat differs from abdominal subcutaneous
fat in HIV-1–infected cART-treated patients with (cART+LD+)
and without (cART+LD2) lipodystrophy.
RESEARCH DESIGN AND METHODS—We used histology,
microarray, PCR, and magnetic resonance imaging to compare
dorsocervical and abdominal subcutaneous adipose tissue in
cART+LD+ (n = 21) and cART+LD2 (n = 11).
RESULTS—Albeit dorsocervical adipose tissue in cART+LD+
seems spared from lipoatrophy, its mitochondrial DNA (mtDNA;
copies/cell) content was signiﬁcantly lower (by 62%) than that of
the corresponding tissue in cART+LD2. Expression of CD68
mRNA, a marker of macrophages, and numerous inﬂammatory
genes in microarray were signiﬁcantly lower in dorsocervical
versus abdominal subcutaneous adipose tissue. Genes with the
greatest difference in expression between the two depots were
those involved in regulation of transcription and regionalization
(homeobox genes), irrespective of lipodystrophy status. There
was negligible mRNA expression of uncoupling protein 1, a gene
characteristic of brown adipose tissue, in either depot.
CONCLUSIONS—Because mtDNA is depleted even in the
nonatrophic dorsocervical adipose tissue, it is unlikely that the
cause of lipoatrophy is loss of mtDNA. Dorsocervical adipose
tissue is less inﬂamed than lipoatrophic adipose tissue. It does
not resemble brown adipose tissue. The greatest difference in
gene expression between dorsocervical and abdominal sub-
cutaneous adipose tissue is in expression of homeobox genes.
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U
se of combination antiretroviral therapy (cART)
is associated with the lipodystrophy syndrome,
which is characterized by loss of adipose tissue
(lipoatrophy) in face, limbs, and abdominal sub-
cutaneous region and accumulation of adipose tissue
(lipohypertrophy) intra-abdominally and subcutaneously
in the dorsocervical upper trunk (buffalo hump) (1). Al-
though lipoatrophy has been extensively studied both in vitro
and in vivo (2–4), lipohypertrophy is poorly understood.
There are no data comparing dorsocervical adipose tissue
(hypertrophic depot) to abdominal subcutaneous adipose
tissue (lipoatrophic depot) from the same individuals and
no existing in vitro models explaining their opposite path-
ophysiology.
There are some but sparse clinical observational data
regarding the buffalo hump. The prevalence of buffalo
hump, as determined by physical examination, has been
estimated to be 2–13% in all HIV-1–infected cART-treated
patients and up to 25% in those with the lipodystrophy
syndrome (5). In a large group of lipodystrophic patients
(n = 417), the presence as compared with the absence of
buffalo hump was associated with higher prevalence of
visceral adiposity and features of insulin resistance such
as fasting serum insulin, C-peptide, and homeostasis model
assessment of insulin resistance (HOMA-IR) (5). In a study
comparing 926 HIV-1–positive (lipodystrophy status not
speciﬁed) with 258 HIV-1–negative subjects, upper trunk
subcutaneous adipose tissue (on both chest and neck,
measured by magnetic resonance imaging [MRI]) was
shown to be associated with insulin resistance as mea-
sured by HOMA-IR independent of obesity parameters
other than intra-abdominal fat (6). In HIV-1–negative sub-
jects, accumulation of dorsocervical adipose tissue has
been associated with general and visceral obesity as well
as other features of the metabolic syndrome (7–9). Thus
the buffalo hump associated with the lipodystrophy syn-
drome may provide an interesting model of hypertrophic
adipose tissue in humans.
It is unclear why in HIV-1–infected cART-treated
patients adipose tissue remains normal or even hypertro-
phies in some areas (e.g., dorsocervically), whereas it at-
rophies in others (e.g., abdominal subcutis and limbs). In
mice, interscapular adipose tissue is known to be brown
adipose tissue (BAT) (10). BAT, as opposed to white adi-
pose tissue, is exceptionally rich in mitochondria (11).
BAT mitochondria express exceptionally high amounts of
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ORIGINAL ARTICLEuncoupling protein 1 (UCP1) (12), a protein responsive for
the main function of BAT: adaptive thermogenesis (13).
Identiﬁcation of UCP1 mRNA in dorsocervical adipose
tissue of patients with the lipodystrophy syndrome (14,15)
has evoked a hypothesis that buffalo hump might be
metabolically active BAT. However, after completion of
the current study, positron emission tomography (PET)
studies have demonstrated that BAT in healthy humans is
localized in supraclavicular rather than dorsocervical re-
gion (16–18). PET studies have not found BAT in subjects
with the lipodystrophy syndrome (19).
In the current study, we compared characteristics of the
dorsocervical and the abdominal subcutaneous adipose
tissue from the same individuals in a group of 32 cART-
treated patients with and without lipodystrophy using
histology, microarray, real-time PCR, and MRI.
RESEARCH DESIGN AND METHODS
Study subjects. After approval of the study protocol by the appropriate Ethics
Committee, 32 study subjects were recruited from the HIV outpatient clinic of
the Helsinki University Central Hospital. All were required to have been on
cART for at least 18 months with unchanged regimen for at least 12 weeks
before the study. The purpose, nature, and potential risks of the study were
explained to the patients, and their written informed consent was obtained. The
participants were subgrouped according to the presence or absence of
lipodystrophy.Lipodystrophywasdeterminedasself-reportedandinvestigator-
conﬁrmed (J.S.) loss of subcutaneous adipose tissue with or without accu-
mulation of adipose tissue intra-abdominally or in the dorsocervical upper
trunk.Subjectsfulﬁllingthesecriteriawereincludedinthelipodystrophicstudy
group (cART+LD+; n = 21). Subjects without lipodystrophy (cART+LD2; n =
11) had received cART without developing the aforementioned changes in
body fat composition. Pregnancy and signs, symptoms, or biochemical evi-
dence of active diseases other than HIV-1 were exclusion criteria. All subjects
were studied after an overnight fast. The study subjects had participated
previously in a study comparing expression of selected genes in abdominal
subcutaneous adipose tissue between lipoatrophic and nonlipoatrophic
patients (20). The lipoatrophic patients have also participated in a clinical
treatment trial with uridine (21). All present data on dorsocervical adipose
tissue as well as microarray and histology data from both dorsocervical and
abdominal subcutaneous adipose tissue are novel.
Surgical subcutaneous adipose tissue biopsies. After local anesthesia with
lidocaine, surgical subcutaneous adipose tissue biopsies were taken from the
midway between the iliac crest and the umbilicus as well as from the midline at
the base of the neck. Part of the biopsy was immediately snap-frozen in liquid
nitrogen, whereas another part was formalin-ﬁxed and parafﬁn-embedded for
subsequent histological analyses.
Analysis of adipose tissue biopsies
Mitochondrial DNA copy numbers. Genomic DNA was extracted from
adipose tissue with the QIAamp DNA isolation kit (Qiagen, Hilden, Germany).
Mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) copy numbers were
determined by quantitative PCR using the ABI 7700 sequence detection system
(Applied Biosystems, Foster City, CA). All samples were run in triplicate.
Absolute mtDNA and nDNA copy numbers were calculated using serial dilu-
tions of plasmids with known copy numbers. Details on primers and exact PCR
methodology have been published previously (20).
Light microscopy. Formalin-ﬁxed, parafﬁn-embedded subcutaneous adipose
tissue samples were sectioned using a standard protocol. The slides were
stained with hematoxylin and eosin and examined under the light microscope
(Nikon Eclipse 80i; Nikon Corporation, Tokyo, Japan) for the amount of con-
nective tissue; vascularization; lipogranulomata, i.e., lipid-laden macrophages
encirclingadipocytes; degreeofadipocytesizevariation;andthepresenceofcell
membrane rupture and brown adipocytes. Images for publication were taken
using the computersoftwarecompatible with the microscope(NIS-Elements 3.0;
Nikon Corporation).
RNA extraction. Adipose tissue per patient (100 mg) was homogenized using
the isolation kit Geneclean (Bio101 systems; Obiogene, Carlsbad, CA). RNA
was extracted with the RNeasy Lipid Tissue Kit (Qiagen, Hilden, Germany)
following the manufacturer’s instructions. Quantity and integrity of RNA were
veriﬁed using RNA 6000 nanochips (Agilent 2100 Bioanalyser; Palo Alto, CA).
Part of the isolated RNA was stored at 280°C until quantiﬁcation of the target
mRNAs by microarray. In addition, of each sample 1.5 mg of RNA were used
for reverse transcription using 400U of Superscript II (Invitrogen, Carlsbad,
CA) and 100 mM of oligo(dT)12–18 (Invitrogen) as primer. Another 0.5 mgo f
RNA was reverse transcribed using the SuperScript VILO cDNA synthesis kit
(Invitrogen).
Microarray. Total RNA (1 mg/sample) was indirectly labeled using the T7
ampliﬁcation method (Amino Allyl MessageAmpTM II aRNA Ampliﬁcation Kit;
Ambion, Austin, TX) according to the manufacturer’s instructions. The am-
pliﬁed RNA (aRNA; 5 mg/sample) was labeled using monoreactive Cy3 or Cy5
dyes (GE Healthcare, GE Life Sciences, Uppsala, Sweden) followed by puri-
ﬁcation according to the manufacturer’s instructions. Labeled aRNAs were
hybridized onto Whole Human Genome 4 3 44 K microarrays (Agilent Tech-
nologies, Santa Clara, CA) according to the manufacturer’s instructions. The
slides were then washed according to the instructions with buffers from
Agilent and scanned with GenePix 4200 AL (Axon Instruments, Molecular
Devices, Silicon Valley, CA) at the resolution of 5 mm/pixel and at 16 bit depth.
Microarrays were technically unsuccessful in four samples and these patients
(all cART+LD+), consequently, were excluded from further analyses. Micro-
array results were analyzed using Benjamini and Hochberg post hoc correc-
tion for multiple comparisons with statistical signiﬁcance set to P # 0.01. The
analysis was carried out as comparison of dorsocervical to the abdominal
subcutaneous adipose tissue in the cART+LD+ and the cART+LD2 group
separately. DAVID Bioinformatics Resources 6.7 (http://david.abcc.ncifcrf.
gov) was used to select over-represented pathways and gene categories (22).
Real-time quantiﬁcation of gene expression. PCR of CD68 was carried
out on a LightCycler 480 (Roche, Penzberg, Germany) using SYBR-Green
technology by Roche as described previously (20). Expression of CD68 was
normalized to the mean of three housekeeping genes (actin b, ACTB; acidic
ribosomal protein P0, 36B4; b2-microglobulin, B2M) commonly used (23). The
PCR for UCP1 was carried out in a subset of samples (n = 6) from individuals
with the clinically largest buffalo humps using ABI PRISM 7900HT instrument
and software (PE Applied Biosystems, Foster City, CA) using Power SYBR
Green PCR Master Mix (PE Applied Biosystems). Expression of UCP1 was
normalized to ACTB. Expression of the homeobox genes (HOXA10, HOXC9,
HOXC8,a n dSHOX2) chosen to verify the microarray results was measured
using SYBR-Green kit according to the manufacturer’s protocol on ABI PRISM
7000 Sequence Detection System instrument and software (PE Applied Bio-
systems). Expression of homeobox genes was normalized to 36B4. All sam-
ples were run in duplicates, and the results were calculated from the real-time
PCR efﬁciency (24). Primers used for PCR analyses are given in Table 1.
Measures of body composition. Body circumferences were measured in
triplicates with a nonstretchable band for the waist midway between the lower
rib margin and the iliac crest and, for the hip circumference, over the greater
trochanters and recorded to the nearest 0.5 cm. Skinfold thickness (mean
values of triplicate measurements) was determined at ﬁve sites (triceps, biceps,
iliac crest, thigh, and scapula) (25). Limb, trunk, and total body fat were
measured using dual-energy X-ray absorptiometry (DEXA; Lunar Prodigy,
Madison, WI). Intra-abdominal fat as well as abdominal and dorsocervical
subcutaneous fat were quantiﬁed by analyzing T1-weighted two-dimensional
fast low angle shot trans-axial MRI scans. Details for image acquisition for
intra-abdominal and abdominal subcutaneous fat have been given previously
(26). Dorsocervical subcutaneous fat volume was measured from scans ac-
quired by the methodology described above covering the area between second
and third cervical vertebra to the lower edge of scapula (slice thickness, 5 mm;
ﬁeld of view, 315 3 500 mm
2; time of repetition, 159 ms; echo time, 4.1 ms).
Liver fat content was measured using proton magnetic resonance spectros-
copy, as previously described (27).
Analytical procedures. Plasma glucose concentrations were measured using
a hexokinase method, serum total, and HDL cholesterol and triglyceride
concentrations with respective enzymatic kits from Roche Diagnostics using
an autoanalyzer (Roche Diagnostics, Hitachi 917; Hitachi, Tokyo, Japan).
The concentration of LDL cholesterol was calculated using the formula of
Friedewald et al. (28). Serum insulin and C-peptide concentrations were deter-
minedby time-resolved ﬂuoroimmunoassay using Insulin and C-peptide Kits
(AUTOdelﬁa, Wallac, Turku, Finland), respectively. HOMA-IR was calculated
from the formula: fasting glucose (mmol/L) 3 fasting insulin (mU/L)/22.5 (29).
Serum ALT activity was determined as recommended by the European
Committee for Clinical Laboratory Standards. Serum C-reactive protein (CRP)
was analyzed using a commercial kit (Ultrasensitive CRP Kit; Orion Diag-
nostica, Espoo, Finland). CD4+ T-cell count was determined using ﬂow-
cytometry (FACSort/FACSCalibur; Becton Dickinson, San José, CA). HIV-1 viral
load was measured using HPS Cobas TaqMan 48n HIV-1 Test (Roche Diag-
nostics, Branchburg, NJ) with a detection limit of 50 copies/mL. Shygmomano-
metric measurement of brachial pressure was conducted after a minimum of
15 min of acclimatization and before blood sampling.
Statistics. Demographic and clinical parameters among the study groups were
compared using Fisher exact test or x
2 test for categorical variables and
unpaired t test or Mann-Whitney test for continuous variables, as appropriate.
Distribution was tested for normality using a Kolmogorov-Smornov test.
Wilcoxon matched pairs test was used to compare intraindividual data.
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For statistical analyses GraphPad Prism version 4 (GraphPad Software, San
Diego, CA) and Lotus 1-2-3 of Lotus SmartSuite Release 9.5 (Lotus De-
velopment Corporation, IBM Corporation, New York, NY) were used. Data are
given as mean 6 SEM or median (25% percentile–75% percentile), as appro-
priate. Two-tailed P values , 0.05 were considered statistically signiﬁcant.
Statistical analyses of the microarray data are described in detail above.
RESULTS
Study subjects. Characteristics of the patients are given
in Table 2. The cART+LD+ and the cART+LD2 groups
were comparable with respect to age, sex, and BMI.
The cART+LD+ group had signiﬁcantly higher ratios
of dorsocervical to abdominal subcutaneous and intra-
abdominal to abdominal subcutaneous adipose tissue
than the cART+LD2 group. Serum insulin, HOMA-IR, and
triglyceride concentrations were signiﬁcantly higher and
HDL cholesterol concentrations lower in the cART+LD+
compared with the cART+LD2 group (Table 2).
Analysis of adipose tissue biopsies
mtDNA copy numbers: dorsocervical versus abdom-
inal subcutaneous adipose tissue. The mtDNA copy
number was signiﬁcantly higher in the dorsocervical than in
the abdominal subcutaneous adipose tissue in the cART+LD+
group (356 6 59 vs. 256 6 44 copies/cell; P = 0.01). A similar
trend was found in the cART+LD2 group (930 6 109 vs.
563 6 161 copies/cell; P = 0.08; Fig. 1).
mtDNA copy numbers: cART+LD+ versus cART+LD2.
The mtDNA copy number was 62% lower in the cART+LD+
than in the cART+LD2 group in the dorsocervical (P ,
0.0001) and 54% lower in the abdominal subcutaneous adi-
pose tissue (P = 0.03; Fig. 1).
Light microscopy: dorsocervical versus abdominal
subcutaneous adipose tissue. The dorsocervical adi-
pose tissue in both the cART+LD+ and the cART+LD2
group had signiﬁcantly less adipocytes (55 6 6 vs. 77 6 5%,
P = 0.01; and 61 6 5 vs. 89 6 4%, P , 0.00001, respectively)
and more connective tissue (45 6 6 vs. 23 6 5%, P = 0.01;
and 39 6 5v s .1 16 4%, P , 0.00001, respectively) than the
abdominal subcutaneous adipose tissue (Fig. 2). The two
depots were similar with respect to variation in adipocyte
size, cell membrane rupture, presence of lipogranulomata,
and cells morphologically typical to BAT irrespective of
the lipodystrophy status (data not shown).
Light microscopy: cART+LD+ versus cART+LD2. The
abdominal subcutaneous adipose tissue from patients
in the cART+LD+ group contained signiﬁcantly more
lipogranulomata (P = 0.045) than the corresponding tissue
from the cART+LD2 group (Fig. 2). Other histological pa-
rameters did not differ signiﬁcantly between the cART+LD+
and the cART+LD2 group in either depot.
Microarray: dorsocervical versus abdominal subcu-
taneous adipose tissue in cART+LD+. Microarray
analysis comparing the dorsocervical to the abdominal
subcutaneous adipose tissue within the cART+LD+ group
identiﬁed 27,819 probes for genes of which 99 were dif-
ferentially expressed. These 99 probes corresponded to
75 unique Entrez gene IDs. Of these 75 genes, 61 were
dowregulated and 14 upregulated in the dorsocervical
compared with the abdominal subcutaneous adipose tissue
(Supplementary Table 1; full microarray data are available
at Gene Expression Omnibus [GEO], http://www.ncbi.nlm.
nih.gov/geo/; accession number GSE28073). The differen-
tially expressed genes were involved in regulation of gene
transcription; organ development; and regionalization, im-
mune response, and inﬂammation as well as in composition
and organization of extracellular matrix and cytoskeleton.
Three of the top six genes downregulated in the dorsocer-
vical adipose tissue were homeobox genes HOXA10,
HOXC9,a n dHOXC8. These genes are known to be tran-
scription factors providing cells with speciﬁc positional
identities on the anterior-posterior axis. Among genes
upregulated in the dorsocervical compared with the ab-
dominal subcutaneous adipose tissue was short stature
homeobox 2 (SHOX2), a gene responsible for cranio-facial
lateralization of the embryonic cells.
Microarray: dorsocervical versus abdominal subcu-
taneous adipose tissue in cART+LD2. Microarray
analysis comparing the dorsocervical to the abdominal
subcutaneous adipose tissue within the cART+LD2 group
identiﬁed 27,900 probes for genes of which 18 were dif-
ferentially expressed. Of these, 13 corresponded to unique
Entrez Gene IDs. Of these 13 genes, 9 were downregulated
and 4 upregulated in the dorsocervical compared with the
abdominal subcutaneous adipose tissue (Supplementary
Table 2; full microarray data are available at GEO, vide
supra). The differentially expressed genes were involved
in regulation of transcription, organ development, and
regionalization. The top three downregulated genes were
the same HOXA10, HOXC9,a n dHOXC8 genes as in the
cART+LD+ group. Also alike in the cART+LD+ group,
SHOX2 was among the genes most upregulated in the
dorsocervical as compared with the abdominal adipose
tissue.
TABLE 1
Primers used for mRNA analyses












*Used as a housekeeping gene in CD68 expression analysis; †used as a housekeeping gene in homeobox gene expression analysis; ‡used as
a housekeeping gene in UCP1 expression analysis.
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quantiﬁcation of expression of homeobox genes in
dorsocervical versus abdominal subcutaneous adi-
pose tissue. Expression of SHOX2 was fourfold higher in
the dorsocervical compared with the abdominal subcuta-
neous adipose tissue in the cART+LD+ and sixfold higher
for the respective comparison in the cART+LD2 group.
Expression of HOXA10, HOXC9,a n dHOXC8 was 18-, 8-,
and 11-fold lower in the dorsocervical compared with the
abdominal subcutaneous adipose tissue in the cART+LD+
group. In the cART+LD2 group, expression of HOXA10,
HOXC9,a n dHOXC8 were 21-, 9-, and 10-fold lower in the
dorsocervical than in the abdominal subcutaneous adipose
tissue. Fold change differences for any of the homeobox
genes analyzed were not signiﬁcantly different between the
cART+LD+ and the cART+LD2 groups (Fig. 3).
Real-time PCR veriﬁcation of the microarray data:
expression of UCP1 in dorsocervical versus abdomi-
nal subcutaneous adipose tissue. UCP1 mRNA was
detected in similar minute quantities in some dorsocervical
and abdominal subcutaneous adipose tissue samples, but
expression was approximately 1,000 times lower than that
measured by the same laboratory in human BAT (data not
shown) (18).
Real-time PCR veriﬁcation of the microarray data:
expression of CD68 mRNA. Expression of CD68 mRNA,
used as a marker of macrophages and, thus, inﬂammation,
was signiﬁcantly lower in the dorsocervical as compared
with the abdominal subcutaneous adipose tissue in the
cART+LD+ group (0.39 [0.08–6.63] vs. 0.56 [0.19–6.48], P =
0.02). The same was true also in the cART+LD2 group
(P = 0.04). Expression of CD68 mRNA did not differ be-
tween the study groups in either adipose tissue depot (data
not shown).
DISCUSSION
Herein we compared in detail the dorsocervical adipose
tissue of cART-treated patients with and without lipodys-
trophy to the abdominal subcutaneous adipose tissue from
TABLE 2
Characteristics of the study groups
cART+LD+ cART+LD2 P value
Men/women 18/3 10/1 0.67
Age 47 6 24 4 6 3 0.28
Body composition
Weight (kg) 74 6 37 5 6 3 0.72
BMI (kg/m
2) 23.6 6 0.7 23.7 6 0.8 0.92
Waist-to-hip ratio 1.00 6 0.01 0.92 6 0.02 ,0.01
Sum of four skinfolds (mm)* 20 6 22 8 6 3 ,0.05
Scapular skinfold (mm) 21 6 31 5 6 2 0.12
Scapular skinfold/sum of four skinfolds* 1.0 6 0.1 0.6 6 0.1 ,0.01
Dorsocervical/abdominal subcutaneous adipose tissue volume 1.0 6 0.1 0.5 6 0.6 ,0.05
Intra-abdominal/abdominal subcutaneous adipose tissue volume 2.3 (0.8–4.5) 0.5 (0.5–0.7) ,0.001
Liver fat (%) 3 (1.5–11.3) 1 (0.75–1.5) ,0.001
Leg fat (g) 1,880 6 370 4,270 6 620 ,0.01
Limb fat of total fat (%) 20 6 23 7 6 1 ,0.001
Trunk fat (g) 9,360 6 1,030 9,380 6 1,450 0.99
Trunk fat of total fat (%) 76 6 25 9 6 1 ,0.001
Total body fat (%) 17 6 22 1 6 3 0.24
Features of insulin resistance
Plasma glucose (mmol/L) 5.1 (4.9–5.7) 5.3 (5.1–5.8) 0.28
Serum insulin (mU/L) 12.8 6 2.4 4.9 6 0.5 ,0.05
Serum C-peptide (nmol/L) 0.85 6 0.09 0.54 6 0.06 ,0.05
HOMA-IR index 2.3 (1.3–4.1) 1.0 (0.9–1.5) ,0.05
Serum HDL cholesterol (mmol/L) 1.2 6 0.1 1.8 6 0.1 ,0.001
Serum LDL cholesterol (mmol/L) 2.7 6 0.2 2.4 6 0.3 0.39
Serum triglycerides (mmol/L) 3.4 6 0.5 1.6 6 0.3 ,0.05
Serum hs-CRP (mg/L) 1.6 6 0.3 0.7 6 0.2 0.08
Serum ALT (units/L) 38 6 62 8 6 4 0.26
Systolic blood pressure (mmHg) 129 6 3 123 6 4 0.21
Diastolic blood pressure (mmHg) 81 6 27 7 6 3 0.28
HIV-related characteristics
Time since HIV-1 diagnosis (years) 9.1 6 1.0 7.8 6 1.3 0.28
Duration of cART (years) 5.9 6 0.4 3.8 6 0.5 ,0.01
Patients with undetectable HIV-1 viral load 18/21 11/11 0.53
Most recent CD4+ T-cell count (cells/mm
3) 545 6 57 522 6 44 0.79
Current NRTI (%) 100 100 NA
Current NNRTI (%) 20 80 ,0.01
Current PI (%) 95 20 ,0.001
Data are shown as mean 6 SEM or median (25% percentile–75% percentile). ALT, alanine aminotransferase; hs-CRP, highly sensitive
C-reactive protein; NA, not applicable; NRTI, nucleoside analog reverse transcriptase inhibitor; NNRTI, nonnucleoside analog reverse tran-
scriptase inhibitor; PI, protease inhibitor. HOMA-IR calculated from the formula: fasting glucose (mmol/L) 3 fasting insulin (mU/L)/22.5 (29).
The concentration of LDL cholesterol was calculated using the formula of Friedewald (28). *The four sites for skinfold thickness measure-
ment, representing the lipoatrophic body parts, were: triceps, biceps, iliac crest, and thigh.
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these two depots are of interest since in lipodystrophic
patients one atrophies (abdominal depot), whereas the
other is spared (dorsocervical depot).
mtDNA. We found that mtDNA copy numbers are signiﬁ-
cantly lower in the dorsocervical and the abdominal sub-
cutaneous adipose tissue of the cART+LD+ group than
in the respective depots in the cART+LD2 group. Dorso-
cervical adipose tissue had signiﬁcantly more mtDNA than
the abdominal subcutaneous adipose tissue in the cART+LD+
group and almost signiﬁcantly (P = 0.08) in the cART+LD2
group. These results conﬁrm previous reports on mtDNA
depletion in lipoatrophic adipose tissue (14,20,30,31). How-
ever, the fact that mtDNA content is highly signiﬁcantly
lower (by 62%) also in the dorsocervical adipose tissue
of cART+LD+ compared with the corresponding tissue in
cART+LD2 while the two depots are phenotypically com-
parable contradicts the prevailing theory that mtDNA de-
pletion causes lipoatrophy. It also implies that once the
lipodystrophy syndrome develops, the derangements ob-
served in the adipose tissue are systemic and not restricted
to atrophic abdominal subcutaneous adipose tissue.
Dorsocervical adipose tissue in the lipodystrophy syn-
drome has been suggested to represent BAT based on its
anatomical location (14,32). Hallmarks of BAT include am-
ple mitochondria featuring high metabolic activity and high
expression of UCP1 (10–12). Previous studies reported
signiﬁcant amounts of UCP1 mRNA in the buffalo hump,
but not in healthy or lipoatrophic abdominal subcutaneous
adipose tissue (14,15). Protein levels of UCP1 were not
quantiﬁed. In our dorsocervical adipose tissue samples, we
did not ﬁnd increased copy numbers of mtDNA compared
with abdominal subcutaneous adipose tissue and found no
evidence of biologically signiﬁcant UCP1 expression us-
ing the same assay as previously used to verify the pres-
ence of UCP1 in BAT in human supraclavicular adipose
tissue studied by PET (18). Moreover, we did not see typical
BAT morphology in our dorsocervical tissue samples, even
in those from the clinically most prominent buffalo humps.
This is in line with a recent study in subjects with cART-
associated lipodystrophy reporting their dorsocervical adi-
pose tissue to lack BAT morphology and not to be activated
by cold exposure like true BAT would (19). Thus the pres-
ent data support the view that dorsocervical adipose tissue
in cART-associated lipodystrophy is not BAT.
Histology. Lipoatrophic adipose tissue, as compared
with nonlipodystrophic adipose tissue, is known to be
characterized by smaller adipocytes, greater cell size
variation, disruption of cell membranes, and signs of
FIG. 1. Number of mtDNA copies per cell in dorsocervical (Dc) and
abdominal subcutaneous (Abd. s.c.) adipose tissue of cART+LD+ and
cART+LD2 patients. Data are given as mean 6 SEM.
FIG. 2. Representative hematoxylin and eosin staining of the dorso-
cervical (top panels) and the abdominal (bottom panels) subcutaneous
adipose tissue from cART+LD+ subjects (left panels) and cART+LD2
subjects (right panels). Original magniﬁcation 3150. The dorsocer-
vical adipose tissue exhibits less adipocytes surrounded by more
prominent connective tissue than the abdominal subcutaneous adipose
tissue. Note the regular structure of both the dorsocervical and the
abdominal subcutaneous adipose tissue in the cART+LD2 subjects—
adipocytes are predominantly equal in size with few blood vessels ob-
served between them. The adipose tissue from the cART+LD+ subjects, in
contrast, tends to show greater cell size variation and more proliferated
vascularization, although these differences do not reach statistical sig-
niﬁcance in our analyses. (A high-quality digital representation of this
ﬁgure is available in the online issue.)
FIG. 3. Mean fold change in mRNA expression (measured by RT-PCR) in
dorsocervical vs. abdominal subcutaneous adipose tissue in cART+LD+
group (black bars) and cART+LD2 group (white bars). Positive values
on the y-axis indicate upregulation and negative values indicate
downregulation of the gene in question in the dorsocervical vs. ab-
dominal subcutaneous adipose tissue. Error bars, SEM.
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compared with nonlipodystrophic adipose tissue (33–35). In
our histological analyses, irrespective of the lipodystrophy
status, we found less adipocytes and more connective tissue
in the dorsocervical than in the abdominal subcutaneous
adipose tissue. Thus these characteristics seem to be in-
trinsic to the dorsocervical location. Hitherto, light micros-
copy and ultrastructural characteristic data of adipose tissue
from lipohypertrophic areas of HIV-1–infected subjects on
cART have only been examined in one small study (n =4 )
(35). Although the study did not specify the anatomical lo-
cation of the lipohypertrophic areas, adipose tissue from
these was reported to show similar, although milder,
changes than those seen in lipoatrophic areas (35). These
could not be quantitated because of the small sample size.
The volume fraction of adipocytes and connective tissue
was not reported but the ﬁnding of lipohypertrophic fat to
be more normal is in line with the present data on lower
CD68 expression and more preserved mtDNA copy
number in the dorsocervical compared with the abdomi-
nal subcutaneous adipose tissue (vide infra).
Inﬂammation. We found expression of CD68 mRNA to be
signiﬁcantly lower in the dorsocervical than in the abdom-
inal subcutaneous adipose tissue in both the cART+LD+
and the cART+LD2 groups. Furthermore, microarray data
suggested that genes involved in immune and inﬂammatory
processes are downregulated in the dorsocervical as com-
pared with the abdominal subcutaneous adipose tissue in
the cART+LD+ group. These ﬁndings are in line with those
of Guallar et al. (14), who found that inﬂammation, as
judged from mRNA expression of TNF-a and CD68,i sm o r e
severe in lipoatrophic abdominal subcutaneous adipose
tissue than in the dorsocervical region, although in the latter
study samples were not from the same subjects.
Homeobox genes. The microarray data suggested that
dorsocervical and abdominal subcutaneous adipose tissue
are largely similar. Using stringent criteria to avoid false-
positive data, of all genes in the genome only less than 100
were differentially expressed. The genes differentially
expressed in both the cART+LD+ and the cART+LD2
groups are most likely to be those different because of the
anatomic location of the tissues. The number of genes dif-
ferentially expressed in the dorsocervical compared with the
abdominal subcutaneous adipose tissue was markedly
greater in the cART+LD+ than the cART+LD2 group. Genes
found to be discrepant between the dorsocervical and the
abdominal subcutaneous depot only within the cART+LD+
group seem to represent characteristic features of lipoa-
trophy (e.g., upregulated inﬂammatory genes).
The foremost difference between dorsocervical and
abdominal subcutaneous adipose tissue was in expression
of the homeobox genes. The difference was observed in
both the lipodystrophic and the nonlipodystrophic adipose
tissue using microarray analysis and conﬁrmed by real-
time PCR. Homeobox genes are evolutionary highly con-
served genes that serve as transcription factors guiding
cells of the embryonal neural tube to migrate to their
destined location and determining the distinctive traits
inherit to the tissue being formed. There are four homeo-
box gene clusters in mammals: HOXA, HOXB, HOXC, and
HOXD (36). Each cluster has several members numbered
in ascending order starting from the anterior boundary of
the central nervous system. Thus, the lower the order
number of a homeobox gene, the more cranially it is lo-
cated. Our ﬁndings are in line with this, since rostral
SHOX2 was overexpressed in dorsocervical compared
with abdominal subcutaneous adipose tissue. The reverse
was true for the caudal homeobox genes HOXA10,
HOXC9, and HOXC8. These data support the validity of
the microarray data and are in line with previous reports of
depot-speciﬁc expression of homeobox genes in human
adipose tissue in vivo (37–40) and in human adipose tissue–
derived preadipocytes (41) and stromal cells (42). These
differences were hypothesized to reﬂect the differentia-
tion stages and adipogenic potential of adipose tissue
depots as also suggested by work in murine models and
cell cultures (43). The above human studies, however,
evaluated expression of homeobox genes in adipose tissue
samples from different locations along the ventrodorsal
(subcutaneous–visceral–retroperitoneal) rather than the
craniocaudal (dorsocervical–abdominal subcutaneous) axis
that was examined in the current study. Of interest, HOXC4,
which was expressed exclusively in BAT (37), was not dif-
ferentially expressed between the two adipose tissue depots
in the present microarray analysis. This fortiﬁes the notion
that dorsocervical adipose tissue in cART-associated lip-
odystrophy is not BAT.
We conclude that mtDNA is highly signiﬁcantly lower (by
62%) even in the nonlipoatrophic dorsocervical adipose
tissue of the cART+LD+ patients when compared with the
corresponding depot of the cART+LD2.T h e r e f o r e ,m t D N A
depletion does not seem to lead to lipoatrophy. In lipo-
dystrophic patients, the dorsocervical adipose tissue is less
inﬂamed than the lipoatrophic abdominal subcutaneous
adipose tissue. It does not resemble BAT. The most marked
difference in gene expression between dorsocervical and
abdominal subcutaneous adipose tissue, irrespective of the
lipodystrophy status, lay in expression of homeobox genes
involved in organogenesis and regionalization. Disparate
expression of such fundamental regulators of transcription
might ultimately contribute to different patterns of differ-
entiation and affect the susceptibility of the adipose tissue
depot to cART-induced toxicity, perhaps making the ab-
dominal subcutaneous depot more vulnerable to atrophy.
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